Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00846846 · ClinicalTrials.gov registry record · Phase 4
PROTECT Continued Access Post Marketing Surveillance Trial
A Phase 4 study, sponsored by Medtronic Vascular.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,018
- Enrollment target
NCT00846846: Completed Phase 4 study, sponsored by Medtronic Vascular.
NCT00846846 is a Phase 4 study that has completed, run by Medtronic Vascular. The registered enrollment target is 1,018 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00846846, a Phase 4 study, has completed, sponsored by Medtronic Vascular.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,018 participants
- Enrollment target
Study Summary
In order to expand safety information in patients treated with the Endeavor Drug Eluting Stent System, or next generation model, a Continued Access (CA) study is added to the PROTECT Trial. The amended study is "PROTECT CONTINUED ACCESS" ("PROTECT CA").
Primary Outcome
The primary endpoint rate of ARC-defined definite or probable stent thrombosis at 3 years.
Interventions
- DEVICE Endeavor® Zotarolimus Eluting Coronary Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,018 participants |
| Start Date | 2009-01 |
| Est. Completion | 2015-03 |
| Phase | Phase 4 |
What the finished NCT00846846 record still lists
NCT00846846 is an interventional study that assigns participants to a tested intervention. Its 1,018 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% higher).
The record links to 0 conditions, and to 1 intervention - of which Endeavor® Zotarolimus Eluting Coronary Stent System is the first listed.
NCT00846846 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00846846 about?
NCT00846846 is a clinical study titled "PROTECT Continued Access Post Marketing Surveillance Trial". In order to expand safety information in patients treated with the Endeavor Drug Eluting Stent System, or next generation model, a Continued Access (CA) study is added to the PROTECT Trial. The amended study is "PROTECT CONTINUED ACCESS" ("PROTECT CA").
What is the current status of trial NCT00846846?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,018 participants. The study started on 2009-01. Estimated completion is 2015-03.
What interventions are being tested in trial NCT00846846?
The interventions under investigation include: Endeavor® Zotarolimus Eluting Coronary Stent System (DEVICE).
Who is sponsoring clinical trial NCT00846846?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00846846's enrollment target sits among peer trials
1,018 66th of 2000 higher than 1,935 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06549595 · 1,018 participants · Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
- NCT02178163 · 1,020 participants · NA
Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
- NCT05225428 · 1,020 participants · NA
Video Education With Result Dependent dIsclosure
- NCT06697600 · 1,020 participants · NA
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia